ARCT
Price
$26.89
Change
-$0.35 (-1.28%)
Updated
Sep 25, 1:36 PM EST
44 days until earnings call
BNTX
Price
$102.53
Change
-$2.11 (-2.02%)
Updated
Sep 25, 2:06 PM EST
42 days until earnings call

Analysis and predictions ARCT vs BNTX

Header iconARCT vs BNTX Comparison
Open Charts ARCT vs BNTXBanner chart's image
Arcturus Therapeutics Holdings
Price$26.89
Change-$0.35 (-1.28%)
Volume$100
CapitalizationN/A
BioNTech SE American Depositary Share
Price$102.53
Change-$2.11 (-2.02%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
ARCT vs BNTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ARCT vs. BNTX commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongSell and BNTX is a StrongSell.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (ARCT: $27.24 vs. BNTX: $104.64)
Brand notoriety: ARCT and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 79% vs. BNTX: 64%
Market capitalization -- ARCT: $724.54M vs. BNTX: $25.09B
ARCT [@Biotechnology] is valued at $724.54M. BNTX’s [@Biotechnology] market capitalization is $25.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 1 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • ARCT’s FA Score: 1 green, 4 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 3 TA indicator(s) are bullish while BNTX’s TA Score has 5 bullish TA indicator(s).

  • ARCT’s TA Score: 3 bullish, 6 bearish.
  • BNTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -4.56% price change this week, while BNTX (@Biotechnology) price change was -7.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.05%. For the same industry, the average monthly price growth was +21.89%, and the average quarterly price growth was +34.13%.

Reported Earning Dates

ARCT is expected to report earnings on Nov 08, 2023.

BNTX is expected to report earnings on Nov 06, 2023.

Industries' Descriptions

@Biotechnology (-3.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ARCT with price predictions.
OPEN
A.I.dvisor published
a Summary for BNTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BNTX($25.1B) has a higher market cap than ARCT($725M). ARCT has higher P/E ratio than BNTX: ARCT (8.99) vs BNTX (5.44). ARCT YTD gains are higher at: 60.613 vs. BNTX (-30.342). BNTX has higher annual earnings (EBITDA): 6.05B vs. ARCT (86.8M). BNTX has more cash in the bank: 15.6B vs. ARCT (323M). ARCT has less debt than BNTX: ARCT (32.2M) vs BNTX (206M). BNTX has higher revenues than ARCT: BNTX (9.18B) vs ARCT (263M).
ARCTBNTXARCT / BNTX
Capitalization725M25.1B3%
EBITDA86.8M6.05B1%
Gain YTD60.613-30.342-200%
P/E Ratio8.995.44165%
Revenue263M9.18B3%
Total Cash323M15.6B2%
Total Debt32.2M206M16%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTBNTX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV16.440.55
+3.46%
XPeng
NXU0.18N/A
+1.73%
Nxu
BRY8.150.08
+0.99%
Berry Corp
OCEA4.05-0.02
-0.49%
Ocean Biomedical
XRX16.09-0.25
-1.53%
Xerox Holdings Corp

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+1.19%
AXON - ARCT
49%
Loosely correlated
-0.36%
ORMP - ARCT
45%
Loosely correlated
-1.14%
CYTK - ARCT
42%
Loosely correlated
-0.93%
DNLI - ARCT
42%
Loosely correlated
-1.51%
INO - ARCT
41%
Loosely correlated
+1.86%
More

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been closely correlated with MRNA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.68%
MRNA - BNTX
75%
Closely correlated
-0.24%
AXON - BNTX
43%
Loosely correlated
-0.36%
SRNEQ - BNTX
37%
Loosely correlated
-2.54%
FGEN - BNTX
33%
Loosely correlated
-6.50%
GMAB - BNTX
33%
Poorly correlated
-1.12%
More